The material selection platform
Plastics & Elastomers
The material selection platform
Plastics & Elastomers
by SpecialChem
Cette page a bien été ajoutée à vos favoris

TOPAS® 6013M-07

TOPAS® 6013M-07 by TOPAS Advanced Polymers is engineered for healthcare applications. It is a glass-clear, heat resistant, high purity cyclic olefin copolymer (COC) medical grade plastic used for drug delivery (syringes, cartridges), blow molded containers, and other medical components requiring heat resistance. Possesses high moisture barrier, excellent biocompatibility and high dimensional stability. Excellent alcohol, acid and alkali resistance. Is suitable for processing by injection molding. Recommended for healthcare including pharmaceutical containers and delivery systems. Steam, EtO and gamma sterilizable. TOPAS® 6013M-074 complies with ISO 10993, US Pharmacopoeia XXIII-Class VI and UL 94 HB flame rating. Listed with USA FDA under Drug Master File 12132 and Device Master File 1043. Available worldwide.
Product Type
Cyclo Olefin > COC
Physical Form

TOPAS® 6013M-07 Properties

Physical Properties

Value & Unit
Test Condition
Test Method
Specific Gravity
1020 kg/m³
( )
ISO 1183
Melt Volume Flow Rate (MVR)
13 cm³/10 min
(260°C, 2.16 kg)
ISO 1133
Melt Mass-Flow Rate (MFR or MFI = Melt Flow Index or MI = Melt Index)
12 g/10min
(260°C, 2.16 kg)

TOPAS® 6013M-07 Processing Guidelines

Injection Molding Properties

Value & Unit
Test Condition
Test Method
Feed Temperature
< 100 °C
Zone 1 Temperature
230 - 260 °C
Zone 2 Temperature
240 - 270 °C
Help us improve the Universal Selector

You can’t find what you are looking for? Please report missing products / suppliers, point out errors, or simply tell us how we could make the Universal Selector better.

Access Reliable
Product Information

Database of 144653 Plastics & Elastomers,
reviewed and updated daily

Improve your Product
Selection Experience

Open your choices, compare products,
ask for samples, contact suppliers

Keep-up with latest
Technical Solutions

Be inspired and never miss again crucial
innovations with our weekly email updates

Back to Top